Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE1
Pancreatic Cancer Recurrence in the Netherlands
- Status
- UNKNOWN
- Phase
- N/A
Recurrence After Whipple's (RAW) Study
- Status
- COMPLETED
- Phase
- N/A
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Distal Pancreatectomy, Minimally Invasive or Open, for Malignancy (DIPLOMA)
- Status
- COMPLETED
- Phase
- NA
PAXG Out in the Country
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pancreatic Adenocarcinoma Signature Stratification for Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
- Status
- RECRUITING
- Phase
- N/A
Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer
- Status
- TERMINATED
- Phase
- N/A
EUS-RFA for Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA
Novel MRI Techniques for Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- N/A
UCSF PANC Cyst Registry
- Status
- RECRUITING
- Phase
- N/A
A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- NA
Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery
- Status
- UNKNOWN
- Phase
- N/A